NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Frazier Healthcare Partners

Frazier Healthcare Partners

Seattle, Washingtonfrazierhealthcare.com

Overview

Frazier Healthcare Partners is a private equity and venture capital firm founded in 1991 that focuses exclusively on the healthcare sector, including services, medical devices, pharmaceuticals, and biopharmaceuticals.

Year Founded

1991

Portfolio Companies

34

Investments

Frazier Healthcare Partners investments
CompanyDateStageLead
Vatica HealthSep 2023Private EquityLead
Iolyx TherapeuticsApr 2023Series ACo-investor
Sudo BiosciencesSep 2022Series ALead
KonovoJul 2022Private EquityLead
KonovoJun 2022Buyout/LBOLead

Key People

Ben Magnano

Managing Partner

Brian Morfitt

General Partner

J.P. Michael

General Partner - Structured Solutions

Nathan Every

General Partner

Philip Zaorski

Partner, General Partner

Lisa Robertson

Operating Partner

Michelle Ortner

Operating Partner (Advisory)

Anthony Draye

Partner, Technology & Innovation

Christina Reszka

Partner

Douglas Hollenbeck

Partner - Structured Solutions

Kent Berkley

Partner

Michael Miraflores

Partner, M&A

Ryan Lucero

Partner

Tanya Hayes

Partner, Human Capital & ESG - Center of Excellence

Vance Shen

Partner

Murphy Caine

COO & Partner, Head of Frazier s CoE Team

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSeattle, Washington
Year Founded1991

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.